This inventor holds 2 USPTO granted patents. Top assignees: Northwestern University, University of Southern California, Other. Active years: 2001-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,221 
1 out of 1,695 
1 out of 834,601 Years Active: 2001-2009
Title: Ann Barlow and Amyloid Beta Research
Introduction
Ann Barlow is an inventor associated with Evanston, Illinois. Her patent work concerns amyloid beta-derived dementing ligands, known as ADDLs, and methods for studying their formation and biological activity. The available information lists 2 patents.
Latest Patents
“ Amyloid β Protein (Globular Assembly and Uses Thereof)” describes ADDLs as soluble, globular, non-fibrillar oligomeric structures formed from amyloid β peptide. These structures can activate specific cellular processes. The invention also covers methods for assaying ADDL formation and presence, examining their binding to receptor proteins, and measuring their cellular activities. It further describes assays and inhibitor molecules targeting cellular signaling molecules activated by ADDLs, as well as molecules that block proteins promoting ADDL formation.
Career Highlights
Barlow’s listed organizational affiliations include Northwestern University. The supplied information also names “Other,” which does not identify a specific organization and is therefore omitted.
Collaborations
The listed collaborators include Todd Morgan and Irina Rozovsky.
Conclusion
Ann Barlow’s patent work focuses on ADDL structures and tools for investigating or inhibiting their formation and cellular effects.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile